| Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency L Warter, CY Lee, R Thiagarajan, M Grandadam, S Lebecque, RTP Lin, ... The Journal of Immunology 186 (5), 3258-3264, 2011 | 118 | 2011 |
| Associations of MHC ancestral haplotypes with resistance/susceptibility to AIDS disease development PO Flores-Villanueva, H Hendel, S Caillat-Zucman, J Rappaport, ... The Journal of Immunology 170 (4), 1925-1929, 2003 | 117 | 2003 |
| Use of human monoclonal antibodies to treat Chikungunya virus infection J Fric, S Bertin-Maghit, CI Wang, A Nardin, L Warter The Journal of infectious diseases 207 (2), 319-322, 2013 | 104 | 2013 |
| A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy AXH Goh, S Bertin-Maghit, S Ping Yeo, A Ho, H Derks, A Mortellaro, ... MAbs 6 (3), 764-772, 2014 | 56 | 2014 |
| Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression CA Winkler, H Hendel, M Carrington, MW Smith, GW Nelson, SJ O’Brien, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 37 (4), 1534-1538, 2004 | 49 | 2004 |
| Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: implications for the timing of … S Bertin-Maghit, D Pang, B O'Sullivan, S Best, E Duggan, S Paul, ... Diabetes 60 (1), 248-257, 2011 | 47 | 2011 |
| Improvement of collagen-induced arthritis by active immunization against murine IL-1β peptides designed by molecular modelling SM Bertin-Maghit, CJ Capini, N Bessis, J Chomilier, S Muller, A Abbas, ... Vaccine 23 (33), 4228-4235, 2005 | 45 | 2005 |
| Active immunization against murine TNFα peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection CJ Capini, SM Bertin-Maghit, N Bessis, PM Haumont, EM Bernier, ... Vaccine 22 (23-24), 3144-3153, 2004 | 38 | 2004 |
| Genomic analysis of Fas and FasL genes and absence of correlation with disease progression in AIDS A Vasilescu, SC Heath, G Diop, H Do, T Hirtzig, H Hendel, S Bertin-Maghit, ... Immunogenetics 56, 56-60, 2004 | 16 | 2004 |
| Large-scale isolation of highly pure “untouched” regulatory T cells in a GMP environment for adoptive cell therapy D Haase, KJ Puan, M Starke, TS Lai, MYL Soh, I Karunanithi, B San Luis, ... Journal of Immunotherapy 38 (6), 250-258, 2015 | 14 | 2015 |
| Implications for the Timing of Tolerizing Immunotherapy S Bertin-Maghit, D Pang, B O’Sullivan, S Best, E Duggan, S Paul, ... strategies 60, 248-257, 2011 | | 2011 |
| IL-1β Produced in Response to Islet Autoantigen Presentation Differentiates T-helper-17 Cells at the Expense of Regulatory T cells: Implications for the Timing of Tolerizing … S Bertin-Maghit, B O'Sullivan, S Best, E Duggan, D Pang, H Thomas, ... Clinical Immunology, S98, 2010 | | 2010 |
| Active immunization (vaccination) against peptides of IL-1β induces self anti-IL-1β antibodies and protects against collagen-induced arthritis N Bessis, S Bertin-Maghit, C Capini, J Chomilier, S Muller, JF Zagury, ... Arthritis Research & Therapy 7, 1-1, 2005 | | 2005 |
| Active immunization against peptides of interleukin-1 beta (IL-1 beta) induces self anti-IL-1 beta antibodies and protects against collagen induced arthritis. N Bessis, S Bertin-Maghit, C Capini, J Chomilier, S Muller, A Therwath, ... ARTHRITIS AND RHEUMATISM 50 (9), S547-S547, 2004 | | 2004 |
